Replies to post #326922 on Avid Bioservices Inc (CDMO)

[biopharm]

It looks like Merck needs PS Targeting IP to beat out Gilead

----

The latest victory in a years-long hepatitis C patent battle between Gilead Sciences and Merck goes to Gilead. On Friday, a federal judge overturned a $2.54 billion verdict against the biotech on grounds that a key Merck patent used to support the infringement lawsuit is invalid.
...
....
https://www.fiercepharma.com/legal/gilead-wins-reversal-2-54b-verdict-merck-hep-c-patent-case

[vieuxcarre]

All these trials as the IP was stolen for pennies